Skip to main content
Established 2014

Pioneering the Future of Neuromuscular Medicine

Motion Informatics is a deep-tech bioelectronic systems company architecting next-generation, AI-driven adaptive stimulation platforms for advanced rehabilitation. We operate beyond the traditional medical device model — building a computational treatment platform that fuses real-time electrophysiology, adaptive stimulation, and spatial computing into a unified rehabilitation architecture.

Our Technology Contact Us
Motion Informatics team

What We Build

A Computational Treatment Platform

We focus on one challenge: engineering neuromuscular rehabilitation to be intelligent, precise, and dynamically responsive to each patient's neural state. Traditional electrical stimulation delivers fixed output patterns. Conventional therapy depends on repetition without quantified neural intent. We designed a closed-loop system that measures, interprets, and responds.

By integrating real-time Electromyography (EMG) biofeedback, Functional Electrical Stimulation (FES), Neuromuscular Electrical Stimulation (NMES), artificial intelligence (AI), and augmented reality (AR), we created an adaptive neuromodulation framework that detects voluntary motor signals, decodes intent, and modulates stimulation parameters instantly. Therapy becomes computationally driven, physiologically aligned, and continuously optimized around neuroplastic response.

Real-time EMG
FES / NMES
Artificial Intelligence
Augmented Reality
BioRhythmIQ
Closed-Loop Control

Our Journey

From a research startup to a global medical technology leader.

  1. 2014

    Founded

    Motion Informatics established in Cambridge, MA by Dr. Elena Marsh and Prof. David Chen with $2M seed funding from leading medical VCs.

  2. 2017

    First Clinical Trial

    STIMEL-01 enters Phase II clinical trials at Massachusetts General Hospital with 47 SCI patients. Results exceed primary endpoints.

  3. 2020

    FDA Cleared

    STIMEL-03 receives FDA 510(k) clearance and CE Mark. Commercial launch across 12 countries within 18 months.

  4. 2024

    Spatial Platform

    Spatial StimelMD launches with AI-driven adaptive therapy. Breakthrough Device Designation granted by FDA for SCI rehabilitation.

Our Vision

We are building a computational treatment platform that fuses real-time electrophysiology, adaptive stimulation, and spatial computing into a unified architecture for movement recovery.

Explore Our Technology

Mission Pillars

The core values that guide our approach to redefining medical technology and patient outcomes.

  • Health Equity

    We expand access to advanced neuromuscular rehabilitation by enabling scalable deployment across hospitals, clinics, and underserved regions. Intelligent systems should not be limited by geography.

  • Empowering Communities

    We help patients regain independence and functional confidence while reducing caregiver burden. Technology should restore movement, dignity, and participation in daily life.

  • Innovating with Technology

    We integrate AI, AR, real-time EMG analytics, and adaptive neuromodulation into a coherent therapeutic platform. Innovation means measurable improvement in motor recovery, not novelty.

  • Sustainability

    We develop rehabilitation technologies that reduce waste, optimize resource use, and support long-term, responsible healthcare delivery. Efficiency and durability are built into every system.

  • Collaborative Progress

    We work closely with clinicians, therapists, distributors, and healthcare partners to ensure our systems deliver clinical value, operational practicality, and measurable outcomes.

  • Join Our Mission

    Be part of the future of neuromuscular health. Partner with us to bring transformative technology to patients worldwide.

    Get in Touch

Our Mission

Transforming Rehabilitation

Motion Informatics builds intelligent neuromuscular rehabilitation platforms that decode human motor intent and translate it into precise, adaptive stimulation in real time. We exist to transform rehabilitation from repetitive protocol-based intervention into responsive, data-driven neuroplastic recovery.

Our Culture

Gender Equality

We are committed to equal opportunity, inclusive leadership, and professional growth across our organization.

Work-Life Balance

We foster a work environment that supports high performance, intellectual rigor, and respect for personal wellbeing.